Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Inventory: 2021-2025

Historic Inventory for InMed Pharmaceuticals (INM) over the last 4 years, with Sep 2025 value amounting to $890,807.

  • InMed Pharmaceuticals' Inventory fell 26.99% to $890,807 in Q3 2025 from the same period last year, while for Sep 2025 it was $890,807, marking a year-over-year decrease of 26.99%. This contributed to the annual value of $961,173 for FY2025, which is 22.76% down from last year.
  • Per InMed Pharmaceuticals' latest filing, its Inventory stood at $890,807 for Q3 2025, which was down 7.32% from $961,173 recorded in Q2 2025.
  • In the past 5 years, InMed Pharmaceuticals' Inventory registered a high of $2.5 million during Q2 2022, and its lowest value of $744,839 during Q4 2023.
  • Moreover, its 3-year median value for Inventory was $1.1 million (2023), whereas its average is $1.1 million.
  • As far as peak fluctuations go, InMed Pharmaceuticals' Inventory spiked by 63.17% in 2022, and later plummeted by 53.84% in 2023.
  • Over the past 5 years, InMed Pharmaceuticals' Inventory (Quarterly) stood at $988,822 in 2021, then surged by 63.17% to $1.6 million in 2022, then plummeted by 53.84% to $744,839 in 2023, then surged by 48.13% to $1.1 million in 2024, then declined by 26.99% to $890,807 in 2025.
  • Its last three reported values are $890,807 in Q3 2025, $961,173 for Q2 2025, and $813,970 during Q1 2025.